Discover the advantages of needle-free vaccines and which companies are developing their own promising delivery solutions in ...

Invivyd, Inc. is a microcap biotech company focusing on antibody-based treatments for infectious diseases like COVID-19.

Scandalous Claims Emerge Linking COVID Vaccines to Severe Health Issues** Emerging reports are raising serious concerns about the safety of COVID-19 vaccines, suggesting a troub ...

Shares of Lonza Group AG (SIX: LONN) fell more than 3% on Wednesday after the company reported full-year 2024 earnings that ...

DelveInsight’s, “Squamous Cell Carcinoma Pipeline Insight” report provides comprehensive insights about 75+ companies and 80+ ...

Request To Download Free Sample of This Strategic Report@ Highlighted with 59 tables and 54 figures, this 141-page report ?Asia Pacific Preventive Vaccines Market 2022-2032 by Vaccine Type, Disease, ...

For each region and country, detailed analysis and annual revenue ($ mn) are available for 2022-2032. The breakdown of all regional markets by country and the breakdown of each national market by ...

The Food and Drug Administration (FDA) last week granted the first approval for UK pharma major AstraZeneca’s Datroway ...

EXUMA Biotech, Corp., a clinical-stage biotechnology company discovering and developing cell and gene immunotherapies for solid and ...

China's National Medical Products Administration (NMPA) approved Innovent Biologics Inc.’s NDA for Dovbleron (taletrectinib), a next-generation ROS1 tyrosine kinase inhibitor (TKI), for treating ...

Merck desperately needs Moderna's mRNA-based Personal Cancer Vaccines ... including significant investments from AstraZeneca and Merck. Although their vaccine candidates remained in early ...

The Government anticipated a £1.7 billion bill for injuries caused by the coronavirus vaccine, the Covid Inquiry has heard.